Does Vitamin B6 Mood Randomized Trial work?

The current Migaku evidence database contains 2 reusable source documents for Vitamin B6 Mood Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Background Several lines of evidence suggest that vitamin B6 has potential as an antidepressant. [Field DT (2026); evidence level 4] - Furthermore, epidemiological evidence points to vitamin B6 deficiency as a risk factor for depression, and to high vitamin B6 levels as protective. [Field DT (2026); evidence level 4] - We also found evidence that participants whose DASS depression scores narrowly failed to meet criterion for moderate depression ( N = 52) experienced a slightly smaller but still statistically substantial reduction in symptoms (partial η 2 = 0.17). [Field DT (2026); evidence level 4] - It plays a crucial coenzyme role in the synthesis of the neurotransmitters serotonin, gamma-aminobutyric acid (GABA) and dopamine, which are central to mood regulation, and it has been shown that increasing availably of vitamin B6 above normal levels increases concentrations of serotonin and GABA. [Field DT (2026); evidence level 4] - Background: A nutritional supplement based on medicinal plants (saffron and ashwagandha), tryptophan, and vitamin B6 could contribute to alleviating/improving mood and associated disorders. [Pages-García C (2024); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.